Literature DB >> 22560419

Anaesthetic plus dilating gel improves pupil dilation for cataract surgery.

Delan Jinapriya1, David R P Almeida, Davin Johnson, Isabella Irrcher, Sherif R El-Defrawy.   

Abstract

OBJECTIVE: To evaluate the efficacy of a combination anaesthetic plus dilating gel (ADG) on pupil dilation (PD) and corneal anaesthesia (KA) compared to traditional preoperative pharmacotherapy for cataract surgery.
DESIGN: Prospective, noninferiority study.
METHODS: We studied 20 consenting adults who experienced unilateral cataracts and underwent routine cataract surgery, receiving the traditional preoperative pharmacologic regimen in the operated eye (control eye): diclofenac 0.1%, gentamicin 0.3%, cyclopentolate 1%, phenylephrine 2.5%, and tropicamide 1% 60 and 20 minutes prior to surgery. They then received tetracaine 0.5% and povidone-iodine 5% 10 minutes prior to surgery; and were given tetracaine 0.5%, povidone-iodine 5%, and lidocaine 2% gel 1 minute prior to surgery. Epinephrine 0.1%, 1 cc per 500 mL bag of balanced saline salt solution was administered during surgery. The nonoperated eye (study eye) received tetracaine 0.5%, povidone-iodine 5%, and 0.35 cc ADG gel (phenylephrine 10%, tropicamide 1%, diclofenac 0.1%, and lidocaine 2%) 60 and 10 minutes prior to surgery. PD and KA were measured at baseline, at 30 minutes, and at 5 minutes prior to surgery, and at 5 minutes after surgery.
RESULTS: There was no difference in PD (p = 0.2634) or KA (p = 0.6058) between the study eyes and the control eyes at baseline. Preoperatively, greater mydriasis was achieved in the study eye (7.95 ± 0.91 mm vs 7.17 ± 1.25 mm; p < 0.0001). There was no significant difference in preoperative KA between the study and control eyes (1.5 ± 2.2 mm vs 1.4 ± 2.1 mm; p = 0.77).
CONCLUSIONS: The combination ADG for preoperative preparation of cataract patients achieves at least equivalent dilation and corneal anaesthesia as the current preoperative pharmacologic regimen.
Copyright © 2012 Canadian Ophthalmological Society. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22560419     DOI: 10.1016/j.jcjo.2012.01.007

Source DB:  PubMed          Journal:  Can J Ophthalmol        ISSN: 0008-4182            Impact factor:   1.882


  3 in total

1.  Comparative study measuring the dilatory effect of a mydriatic device (Mydriasert(®)) versus topical drops.

Authors:  Manuel Saenz-de-Viteri; Patricia Fernández-Robredo; Elisa de Nova; Elvira Bonet-Farriol; Alfonso L Sabater; Javier Zarranz-Ventura; Josemaria Caire; Luis M Sádaba; Angel Salinas-Alamán; Alfredo García-Layana
Journal:  Int J Ophthalmol       Date:  2013-12-18       Impact factor: 1.779

2.  Pupil dilation using drops vs gel: a comparative study.

Authors:  E Moisseiev; D Loberman; E Zunz; A Kesler; A Loewenstein; J Mandelblum
Journal:  Eye (Lond)       Date:  2015-04-10       Impact factor: 3.775

3.  Evaluating the potentiating effect of amethocaine on tropicamide-induced mydriasis in darkly pigmented irides, using infrared pupillometry.

Authors:  Olufunmilola A Ogun; Jeffrey W Oliver; Adeyinka O Ashaye; Benedictus Gk Ajayi
Journal:  Ophthalmol Eye Dis       Date:  2014-04-08
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.